To investigate the expression levels of HOXA1 in GBM, we examined the HOXA1 mRNA levels in tumor tissues from 40 patients with glioma (WHO I and II, n = 20; WHO III and IV, n = 20) and 20 normal brain tissues using qPCR. This evidence concerns the gene HOXA1 and central nervous system cancer.